These stocks were in great health last financial year. The post These 5 ASX 200 healthcare shares gained the most weight in ...

ResMed’s first quarter results were met with a strong market response, reflecting in-line revenue and profit performance alongside notable margin expansion. Management credited manufacturing and ...

What trends should we look for it we want to identify stocks that can multiply in value over the long term? One ...

ResMed (RMD) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- ...

ResMed is taking a “smart devices” and Big Data approach to further entrench itself as one of the two leading players in the global obstructive sleep apnea, or OSA, market.

ResMed (NYSE: RMD), a medical equipment company, has seen an 18% fall in a month, underperforming the broader S&P500 index, up 1%. The recent fall can be attributed to its downbeat Q4 fiscal 2023 ...

Part of Air11 Solutions, key features include Care Check-in, Personal Therapy Assistant, among others to provide support to patients and insights to clinicians and providers when used with AirView ...

The ResMed app packs a lot of information into a small space, so it may look overwhelming at first, but all the data is colorfully and minimally presented. There's no wearable component to the S+.

ResMed, the sleep apnea market leader, experienced sales growth during COVID and due to a competitor's product recall. Learn more about RMD stock here.

In the updated instructions for use, ResMed warned that magnet-equipped masks should always be kept at least six inches away from any implants that may be susceptible to magnetic interference ...